Results 21 to 30 of about 65,782,767 (266)

Prognostic value of left atrial reverse remodelling in heart failure with preserved ejection fraction

open access: yes, 2023
Objectives Left atrial reverse remodelling (LARR) reflects an improvement in the function or structure. However, it is unclear whether the presence of LARR is associated with better outcomes in patients with heart failure with preserved ejection ...
Zhao, Shuang   +8 more
core   +1 more source

From Systemic Inflammation to Myocardial Fibrosis: The Heart Failure with Preserved Ejection Fraction Paradigm Revisited

open access: yes, 2021
In accordance with the comorbidity-inflammation paradigm, comorbidities and especially metabolic comorbidities are presumed to drive development and severity of heart failure with preserved ejection fraction through a cascade of events ranging from ...
Paulus, Walter J., Zile, Michael R.
core   +1 more source

Exercise training in heart failure with preserved and reduced ejection fraction: A systematic review and meta-analysis [PDF]

open access: yes, 2022
Background While exercise training (ET) is an established tool in heart failure (HF), no research to date has analysed the efficacy of ET in both preserved (HFpEF) and reduced (HFrEF) ejection fraction phenotypes across the same clinically important ...
O'Driscoll, J., Edwards, J.
core   +1 more source

Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines

open access: yesESC Heart Failure, 2020
Currently, the assessment of left ventricular ejection fraction (LVEF) is the cornerstone of the classification of patients with heart failure (HF). The mid‐range LVEF (HFmrEF) category was identified in an attempt to uncover specific characteristics of ...
Luca Branca   +3 more
doaj   +1 more source

Heart Failure with Preserved Ejection Fraction (HFpEF): A Case Report

open access: yesMajalah Kardiologi Indonesia, 2021
Background: The prevalence of Heart Failure with Preserved Ejection Fraction (HFpEF) currently reaches 50% of heart failure cases and continues to increase every year.
Amanda Halimi, Nani Hersunarti
doaj   +1 more source

Heart Failure with Preserved Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction

open access: yesArquivos Brasileiros de Cardiologia, 2015
Background: The prevalence and clinical outcomes of heart failure with preserved left ventricular ejection fraction after acute myocardial infarction have not been well elucidated. Objective: To analyze the prevalence of heart failure with preserved left
Lucas Antonelli   +9 more
doaj   +1 more source

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides

open access: yesFrontiers in Cardiovascular Medicine, 2021
This review summarizes current knowledge regarding clinical epidemiology, pathophysiology, and prognosis for patients with HFmrEF in comparison to HFrEF and HFpEF. Although recommended treatments currently focus on aggressive management of comorbidities,
Kaiyuan Zhu   +8 more
doaj   +1 more source

Combination of SVI/S′ and diagnostic scores for heart failure with preserved ejection fraction

open access: yes, 2023
The diagnosis of heart failure with preserved ejection fraction (HFpEF) remains a challenge. There are three methods proposed as diagnostic tools. H2FPEF score was determined by six weighted clinical characteristics and echocardiographic variables. Heart
Tse, Gary   +11 more
core   +1 more source

Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes [PDF]

open access: yes, 2022
International audienceBackground: Empagliflozin improves outcomes in patients with heart failure with a preserved ejection fraction, but whether the effects are consistent in patients with and without diabetes remains to be elucidated.
Farmakis, Dimitrios   +22 more
core   +1 more source

during exercise in heart failure with preserved ejection fraction

open access: yes, 2021
Aims: To determine whether inorganic nitrite improves peripheral and pulmonary oxygen (O2) transport during exercise in heart failure with preserved ejection fraction (HFpEF). Methods and results: Data from two invasive, randomized, double-blind, placebo-
Katlyn E. Koepp   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy